Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial

Autor:	Nasser K. Altorki, Zachary H. Walsh, Johannes C. Melms, Jeffery L. Port, Benjamin E. Lee, Abu Nasar, Cathy Spinelli, Lindsay Caprio, Meri Rogava, Patricia Ho, Paul J. Christos, Ashish Saxena, Olivier Elemento, Bhavneet Bhinder, Casey Ager, Amit Dipak Amin, Nicholas J. Sanfilippo, Vivek Mittal, Alain C. Borczuk, Silvia C. Formenti, Benjamin Izar, Timothy E. McGraw
Jazyk:	angličtina
Rok vydání:	2024
Předmět:	Science
Zdroj:	Nature Communications, Vol 15, Iss 1, Pp 1-1 (2024)
Druh dokumentu:	article
ISSN:	2041-1723
DOI:	10.1038/s41467-023-44575-3
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/52eb86e83ce04383a4f75d1460b549c4 Zobrazit plný text záznamu Full text from SpringerLink View record in DOAJ